On August 19, INNOCARE released its interim report for the first half of 2025.
According to the announcement, the company recorded operating revenue of 731,434,172.32 yuan for the six-month period, representing a 74.26% year-over-year increase. The net profit attributable to shareholders of the listed company was -30,091,411.19 yuan.
The announcement also revealed changes among the top ten tradable shareholders, with Bank of China Limited - E Fund Healthcare Industry Hybrid Securities Investment Fund and China Construction Bank Corporation - Bosera Innovation Healthcare Theme Hybrid Securities Investment Fund being newly added as tradable shareholders.